Cargando…
A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882238/ https://www.ncbi.nlm.nih.gov/pubmed/35220684 http://dx.doi.org/10.1002/ctm2.734 |
_version_ | 1784659649554808832 |
---|---|
author | Su, Ganglin Yao, Lin Han, Xiaohong Liao, Xinhui Chen, Jieqing Yin, Tao Dong, Ying Li, Yanfeng Hu, Kun Xiao, Junwen Liu, Yuchen Huang, Weiren Mei, Hongbing |
author_facet | Su, Ganglin Yao, Lin Han, Xiaohong Liao, Xinhui Chen, Jieqing Yin, Tao Dong, Ying Li, Yanfeng Hu, Kun Xiao, Junwen Liu, Yuchen Huang, Weiren Mei, Hongbing |
author_sort | Su, Ganglin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8882238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88822382022-03-02 A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression Su, Ganglin Yao, Lin Han, Xiaohong Liao, Xinhui Chen, Jieqing Yin, Tao Dong, Ying Li, Yanfeng Hu, Kun Xiao, Junwen Liu, Yuchen Huang, Weiren Mei, Hongbing Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-02-27 /pmc/articles/PMC8882238/ /pubmed/35220684 http://dx.doi.org/10.1002/ctm2.734 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to Editor Su, Ganglin Yao, Lin Han, Xiaohong Liao, Xinhui Chen, Jieqing Yin, Tao Dong, Ying Li, Yanfeng Hu, Kun Xiao, Junwen Liu, Yuchen Huang, Weiren Mei, Hongbing A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression |
title | A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression |
title_full | A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression |
title_fullStr | A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression |
title_full_unstemmed | A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression |
title_short | A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression |
title_sort | synthetic targeted rna demethylation system based on crispr‐cas13b inhibits bladder cancer progression |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882238/ https://www.ncbi.nlm.nih.gov/pubmed/35220684 http://dx.doi.org/10.1002/ctm2.734 |
work_keys_str_mv | AT suganglin asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT yaolin asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT hanxiaohong asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT liaoxinhui asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT chenjieqing asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT yintao asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT dongying asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT liyanfeng asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT hukun asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT xiaojunwen asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT liuyuchen asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT huangweiren asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT meihongbing asynthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT suganglin synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT yaolin synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT hanxiaohong synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT liaoxinhui synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT chenjieqing synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT yintao synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT dongying synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT liyanfeng synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT hukun synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT xiaojunwen synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT liuyuchen synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT huangweiren synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression AT meihongbing synthetictargetedrnademethylationsystembasedoncrisprcas13binhibitsbladdercancerprogression |